INDERAL-LA 80 MG
PROPRANOLOL HYDROCHLORIDE : 80 MG · DIN 02042258 · PFIZER CANADA ULC
Health Canada status: CANCELLED POST MARKET
What is INDERAL-LA?
INDERAL-LA 80 MG contains PROPRANOLOL HYDROCHLORIDE : 80 MG. It is listed in the Health Canada Drug Product Database under DIN 02042258, held by PFIZER CANADA ULC, supplied as CAPSULE (EXTENDED RELEASE) for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 31-May-2022. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is INDERAL-LA used for?
INDERAL-LA (propranolol hydrochloride extended-release capsules, USP) is indicated for: maintenance therapy in the treatment of hypertension, and prophylaxis of angina pectoris. The long-acting formulation may then be used for maintenance therapy, provided the dosage requirement is suitable.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
What else is INDERAL-LA called?
The same molecule, PROPRANOLOL, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| Inderal | Latin | Australia, Sweden |
| APO-Propranolol | Latin | Australia |
| Inderal® | Latin | Sweden |
| Propranolol Medical Valley | Latin | Sweden |
| PROPRANOLOL-WGR | Latin | Australia |
| Prodorol | Latin | South Africa |
| Properal | Latin | Saudi Arabia |
| Propranolol Accord | Latin | Sweden |
| Propranolol Ebb | Latin | Sweden |
| AVLOCARDYL | Latin | Morocco |
| AVLOCAN | Latin | Morocco |
| AVLOCARDYL LP | Latin | Morocco |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
Product details and regulatory record
| DIN | 02042258 |
|---|---|
| Brand name | INDERAL-LA |
| Generic / active ingredient | PROPRANOLOL HYDROCHLORIDE : 80 MG |
| Manufacturer | PFIZER CANADA ULC |
| Strength | 80 MG |
| Dosage form | CAPSULE (EXTENDED RELEASE) |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | C07AA05 PROPRANOLOL |
| AHFS class | 24:24.00 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 31-May-2022 |
| Original market date | 1994-12-31 00:00:00 |
How is this product identified?
Purchase orders, customs paperwork and tender documents each ask for a different identifier, and a DIN written without its leading zeros is the single most common reason an order line fails to match. Every form Nexara accepts for this product is listed here.
| DIN (8-digit, as used in Nexara ordering) | 02042258 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2042258 |
| Brand name | INDERAL-LA |
| Active ingredient / INN | PROPRANOLOL HYDROCHLORIDE : 80 MG |
| ATC code | C07AA05 |
| ATC anatomical main group | C — Cardiovascular system |
| ATC therapeutic subgroup | C07 |
| AHFS class | 24:24.00 |
| Health Canada schedule | Prescription |
| Biosimilar biologic | No |
| Market authorization holder | PFIZER CANADA ULC |
How is it stored and handled?
null
How is it supplied?
Bottles of 100 capsules.
Which pack is which?
| Strength on the label | 80 MG |
|---|---|
| Dosage form | CAPSULE (EXTENDED RELEASE) |
| Route | ORAL |
| Packaging as described in the monograph | Bottles of 100 capsules. |
| Storage | null |
One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced. Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
What can be used instead?
Other Canadian products sharing ATC code C07AA05 PROPRANOLOL. 13 of 56 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| HEMANGIOL | 3.75 MG | SOLUTION | PIERRE FABRE DERMO-COSMETIQUE CANADA INC | MARKETED | DIN 02457857 |
| LUPIN-PROPRANOLOL LA | 120 MG | CAPSULE (EXTENDED RELEASE) | LUPIN PHARMA CANADA LIMITED | MARKETED | DIN 02491915 |
| LUPIN-PROPRANOLOL LA | 160 MG | CAPSULE (EXTENDED RELEASE) | LUPIN PHARMA CANADA LIMITED | MARKETED | DIN 02491923 |
| LUPIN-PROPRANOLOL LA | 60 MG | CAPSULE (EXTENDED RELEASE) | LUPIN PHARMA CANADA LIMITED | MARKETED | DIN 02491893 |
| LUPIN-PROPRANOLOL LA | 80 MG | CAPSULE (EXTENDED RELEASE) | LUPIN PHARMA CANADA LIMITED | MARKETED | DIN 02491907 |
| PROPRANOLOL HYDROCHLORIDE INJECTION USP | 1 MG | SOLUTION | SANDOZ CANADA INCORPORATED | MARKETED | DIN 02225883 |
| PRZ-PROPRANOLOL | 20 MG | TABLET | PHARMARIS CANADA INC | MARKETED | DIN 02550814 |
| PRZ-PROPRANOLOL | 40 MG | TABLET | PHARMARIS CANADA INC | MARKETED | DIN 02550822 |
| PRZ-PROPRANOLOL | 80 MG | TABLET | PHARMARIS CANADA INC | MARKETED | DIN 02550830 |
| TEVA-PROPRANOLOL | 10 MG | TABLET | TEVA CANADA LIMITED | MARKETED | DIN 00496480 |
Who else supplies PROPRANOLOL worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. PROPRANOLOL appears in 157 registered pack listings across 14 markets, published on 11 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How much does PROPRANOLOL cost around the world?
PROPRANOLOL is listed on 13 national price registers Nexara tracks, across 176 pack listings published on 11 different price bases. What each country publishes is set out below.
| Market | What that country publishes | Brands listed | Pack listings | As of |
|---|---|---|---|---|
| United States | acquisition | 7 | 91 | 03 Sep 2026 |
| Australia | ex-manufacturer | 5 | 16 | 08 Sep 2026 |
| Sweden | AIP (pharmacy purchase price) | 5 | 16 | 03 Sep 2026 |
| South Africa | single exit price | 9 | 11 | 01 Sep 2026 |
| United Kingdom | hospital | 9 | 9 | 31 Aug 2026 |
| Romania | max producer price | 6 | 9 | 03 Sep 2026 |
| Saudi Arabia | public | 6 | 8 | 01 Sep 2026 |
| Morocco | PPV (public price) | 3 | 4 | 05 Sep 2026 |
| United Arab Emirates | public | 3 | 3 | 31 Aug 2026 |
| Spain | PVP con IVA (public price) | 3 | 3 | 05 Sep 2026 |
| Hungary | producer price (ex-factory) | 3 | 3 | 03 Sep 2026 |
| Greece | producer price (ex-factory) | 2 | 2 | 03 Sep 2026 |
| Slovakia | categorised final price | 1 | 1 | 02 Sep 2026 |
Why there are no figures here. These bases are not comparable. A Brazilian ex-factory ceiling, a Belgian pharmacy public price and a Japanese reimbursement rate answer three different questions, and none of them is what a product lands in Canada for. Putting them side by side would mislead in both directions, so Nexara publishes where a molecule is listed and on what basis, and quotes the delivered Canadian price per order.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.